BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33544472)

  • 1.
    Li Y; Guo S; Zhao K; Conrad C; Driescher C; Rothbart V; Schlomann U; Guerreiro H; Bopp MH; König A; Carl B; Pagenstecher A; Nimsky C; Bartsch JW
    Biol Chem; 2021 Jan; 402(2):195-206. PubMed ID: 33544472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells.
    Dong F; Eibach M; Bartsch JW; Dolga AM; Schlomann U; Conrad C; Schieber S; Schilling O; Biniossek ML; Culmsee C; Strik H; Koller G; Carl B; Nimsky C
    Neuro Oncol; 2015 Nov; 17(11):1474-85. PubMed ID: 25825051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its Aggressiveness.
    Schäfer A; Evers L; Meier L; Schlomann U; Bopp MHA; Dreizner GL; Lassmann O; Ben Bacha A; Benescu AC; Pojskic M; Preußer C; von Strandmann EP; Carl B; Nimsky C; Bartsch JW
    Front Oncol; 2022; 12():826273. PubMed ID: 35371977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.
    Henry A; Nokin MJ; Leroi N; Lallemand F; Lambert J; Goffart N; Roncarati P; Bianchi E; Peixoto P; Blomme A; Turtoi A; Peulen O; Habraken Y; Scholtes F; Martinive P; Delvenne P; Rogister B; Castronovo V; Bellahcène A
    Oncotarget; 2016 Sep; 7(39):63708-63721. PubMed ID: 27563812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
    Szulzewsky F; Schwendinger N; Güneykaya D; Cimino PJ; Hambardzumyan D; Synowitz M; Holland EC; Kettenmann H
    Neuro Oncol; 2018 Feb; 20(3):355-366. PubMed ID: 29016864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.
    Romagnoli M; Mineva ND; Polmear M; Conrad C; Srinivasan S; Loussouarn D; Barillé-Nion S; Georgakoudi I; Dagg Á; McDermott EW; Duffy MJ; McGowan PM; Schlomann U; Parsons M; Bartsch JW; Sonenshein GE
    EMBO Mol Med; 2014 Feb; 6(2):278-94. PubMed ID: 24375628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.
    Brunckhorst MK; Wang H; Lu R; Yu Q
    Cancer Res; 2010 Sep; 70(18):7283-93. PubMed ID: 20823154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection.
    Bartsch JW; Wildeboer D; Koller G; Naus S; Rittger A; Moss ML; Minai Y; Jockusch H
    J Neurosci; 2010 Sep; 30(36):12210-8. PubMed ID: 20826683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma.
    Liu X; Huang Y; Qi Y; Wu S; Hu F; Wang J; Shu K; Zhang H; Bartsch JW; Nimsky C; Dong F; Lei T
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
    Sriraman V; Eichenlaub-Ritter U; Bartsch JW; Rittger A; Mulders SM; Richards JS
    Biol Reprod; 2008 Jun; 78(6):1038-48. PubMed ID: 18287572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
    Ji T; Zhang X; Li W
    Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
    Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
    PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metalloproteinase ADAM8 promotes leukocyte recruitment in vitro and in acute lung inflammation.
    Dreymueller D; Pruessmeyer J; Schumacher J; Fellendorf S; Hess FM; Seifert A; Babendreyer A; Bartsch JW; Ludwig A
    Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L602-L614. PubMed ID: 28596294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasorin stimulates malignant progression and angiogenesis in glioma.
    Liang W; Guo B; Ye J; Liu H; Deng W; Lin C; Zhong X; Wang L
    Cancer Sci; 2019 Aug; 110(8):2558-2572. PubMed ID: 31215106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
    Wei J; Marisetty A; Schrand B; Gabrusiewicz K; Hashimoto Y; Ott M; Grami Z; Kong LY; Ling X; Caruso H; Zhou S; Wang YA; Fuller GN; Huse J; Gilboa E; Kang N; Huang X; Verhaak R; Li S; Heimberger AB
    J Clin Invest; 2019 Jan; 129(1):137-149. PubMed ID: 30307407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
    Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
    J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.